首页> 外国专利> Affinity fractionation of heparin on immobilized Concanavalin A

Affinity fractionation of heparin on immobilized Concanavalin A

机译:肝素在固定化伴刀豆球蛋白A上的亲和分级分离

摘要

A highly discriminating technique utilizing Concanavalin A, immobilized on a solid substrate, e.g. sepharose 4B, for the fractionation of heparin is disclosed. The heparin to be fractionated is incubated with antithrombin whereby a fraction complete with the antithrombin and the whole is then either passed through a column of the immobilized Concanavalin A or slurried with same. In both modes that fraction of the heparin complexed with the antithrombin is selectively absorbed by the immobilized Concanavalin A and constitutes the anticoagulant active fraction. That heparin which complexes with the antithrombin can be further fractionated to yield yet more highly active fractions by complexing the heparin in stages, adding an increment of a molar amount of antithrombin in each stage. A high molecular weight fraction (18,000-22,000 daltons) or a low molecule weight fraction (6,000- 8,000 daltons), isolated from the heparin of animal tissue origin by chromatography, are the preferred heparin preparations for complexing with the antithrombin.
机译:利用伴刀豆球蛋白A的高度区分技术,该刀豆蛋白A固定在固体底物上,例如公开了用于肝素分级分离的琼脂糖凝胶琼脂糖凝胶4B。将要分馏的肝素与抗凝血酶一起温育,从而将完整的馏分与抗凝血酶混合,然后将其全部通过固定的伴刀豆球蛋白A的柱或用其制成浆液。在两种模式中,与抗凝血酶复合的肝素部分均被固定化的伴刀豆球蛋白A选择性吸收,并构成抗凝活性部分。与抗凝血酶复合的肝素可以进一步分级分离,通过分阶段复合肝素,在每个阶段增加摩尔量的抗凝血酶来产生更高活性的馏分。通过色谱法从动物组织来源的肝素中分离出的高分子量级分(18,000-22,000道尔顿)或低分子量级分(6,000-8,000道尔顿)是与抗凝血酶复合的优选肝素制剂。

著录项

  • 公开/公告号US4539398A

    专利类型

  • 公开/公告日1985-09-03

    原文格式PDF

  • 申请/专利权人 RIKER LABORATORIES INC.;

    申请/专利号US19840569551

  • 发明设计人 ROBERT D. ROSENBERG;

    申请日1984-01-09

  • 分类号C08B37/10;

  • 国家 US

  • 入库时间 2022-08-22 07:52:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号